Share This Page

Peter Berger

FDA Approves Aduhelm, New Alzheimer’s Drug

BREAKTHROUGH: FOR THE FIRST TIME in 18 years, the FDA approved a new Alzheimer’s drug. The new medication’s generic name is aducanumab and will be marketed under the brand name Aduhelm. Another first is the drug’s ability to potentially slow down Alzheimer’s, not just cover up its symptoms, as existing medications do. Find out more.

Read More »
You Might Also Like

Recent Stories

Slice of chocolate cake

Diet’s Effect on 500,000 British Brains

Our change in diet has been proposed as being the underlying reason for the dramatic increase in the prevalence of Type II diabetes that we are observing worldwide in our time. What’s that doing to our brains?

Scanning a brain (Courtesy University of Michigan press release)

USA Dementia Diagnosis is Double Trouble

In the USA, the same person may be twice as likely to be told they have dementia, depending on where they are diagnosed. Learn more to get a more accurate test and better treatment.

On Trend

Most Popular Stories

Grandmother in black and white striped shirt hugging girl in black and white striped shirt

A Grandchild for One Day Keeps Dementia Away

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?

Get The Latest Updates

Subscribe To Our Weekly Newsletter

No spam, only news and updates.

Books

Amazon Books
Amazon Books

Social Media

Categories

New Posts

News, Treatments, Care Tips, Diet

Alzheimer's & Dementia Weekly Newsletter: Free

Free. Care & Treatment. Research & Prevention

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

News to Get at the Truth

Subscribe To Our Weekly Newsletter